UBS Raises Jabil Price Target to $152 From $128, Maintains Neutral Rating
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
165.41 USD | -0.21% |
|
+1.85% | +14.95% |
Feb. 04 | Jabil Buys Pharmaceutics International for Undisclosed Sum | MT |
Feb. 03 | Jabil Inc. acquired Pharmaceutics International, Inc. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration